611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line

NurseWise 24-Hour Crisis Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Basic InformationLatest News
Many With Advanced Cancer Want Secondary Germline Findings InfoSecondhand Smoke Still Plagues Some Cancer SurvivorsBig Gap in Cancer Deaths Between Rich, Poor CountriesMany Doctors Silent on Cost of Cancer CareFamily Hx, Mutation Position Key Variables in BRCA1/2 Cancer RiskWeight-Loss Program Aids Black Breast Cancer SurvivorsWhen Is Risk Highest for Women With Breast Cancer Gene Mutations?Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?Childhood Chemo May Have Lasting Effects on MemoryNovel Biomarkers Identified for Prostate Cancer in Non-BlacksModified Colorectal CA Screening Score Improves Risk PredictionRisk of HPV-Linked Second Cancers Up After Anal Cancer'Couch Potatoes' May Face Higher Risk of Kidney, Bladder CancersHealth Tip: Help Prevent Skin CancerWith Summer Sun Comes Heightened Skin Cancer RiskYoung CA Survivors More Often Have Cost-Related NonadherenceCertain Cancer Diagnoses Up in High-Income Counties in U.S.Liver Cancer the Fastest-Growing Cause of Cancer Deaths in U.S.Is Full Lymph Node Removal Always Needed for Melanoma?More Cancers Caught in Wealthy PeopleNurse-Led Psych Intervention Beneficial in Breast CancerU.S. Liver Cancer Deaths Have Doubled Since 1980s: StudyASCO: Industry Perks Influence Physicians' Choice of Cancer RxASCO: SWOG Trials Have Had Considerable Impact on CancerASCO: CAR T-Cell Therapy Promising in Multiple MyelomaPublicly Funded Cancer Trials Gained Americans 3 Million More YearsCan Drug Company Perks Sway Cancer Docs' Prescriptions?ASCO: Abiraterone Extends Survival in Metastatic Prostate CAASCO: Gene-Targeted Drug Shows Efficacy for Child, Adult CancersGene-Based Therapy May Thwart a Tough Blood CancerGene-Targeted Drugs Fight Advanced Lung CancersCancer Drug Helps Some Kids With Rare Type of LeukemiaDrug Helps Fight Breast Tumors Tied to 'Cancer Genes'Reporting Symptoms Online to Docs Helps Cancer Patients Live LongerDrug Extends Lives of Patients With Advanced Prostate Cancer: StudiesPregnancy Doesn't Raise Odds for Breast Cancer's ReturnExperimental Gene-Targeted Drug Hits Cancer Where It LivesChildhood Cancer Survivors Now Living Healthier LivesConquering One Big Cancer Side Effect: FearDark Skin No Shield From Deadly Skin CancerCertain Breast CA Patients Benefit From Adjuvant CapecitabineDrug Xeloda Prolongs Survival for Some Breast Cancer PatientsHigh Costs for Myeloma Patients Not Getting Low-Income SubsidyDaily Texting Effectively Monitors Rx Adherence, Side EffectsScientists Report Progress on Genetic Test for Anal CancerLocation of Body Fat Can Indicate Obesity-Related Cancer RiskBlood Test for Earlier Detection of Pancreatic Cancer FeasibleSocial Contagion Impacts Imaging Use in Breast CancerNew Drug Approved for All Cancers With Genetic MarkerFDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Second Cancers Deadlier for Younger People: Study

HealthDay News
by -- Robert Preidt
Updated: Apr 20th 2017

new article illustration

THURSDAY, April 20, 2017 (HealthDay News) -- When a second cancer strikes, it tends to be far more deadly in the young, a new study reveals.

The findings may help explain the poor outcomes of younger cancer patients overall, the researchers added.

The researchers also found that survival odds for nearly all types of cancer are better for an initial cancer than for a second, unrelated cancer. That difference is greatest among patients younger than 40, the study authors said.

"Although the increased incidence of second cancers is well known among cancer survivors, less is known about outcomes of these cancers or the influence of age," said study author Theresa Keegan.

Keegan is a cancer epidemiologist at the University of California, Davis Comprehensive Cancer Center.

The researchers analyzed 1992-2008 data on more than 1 million cancer patients of all ages in the United States. They then looked for second cancers, meaning a new cancer, not a recurrence.

They found that the five-year survival rate for children and young adults was 80 percent after a first cancer. However, it dropped to 47 percent for children and 60 percent for young adults in cases of second cancers, Keegan and her colleagues said in a university news release.

Meanwhile, survival rates in older adults were 70 percent and 61 percent, respectively.

When the researchers focused on the 14 most common cancer types that affect young adults, they found that for all but two, there were significant survival differences depending on whether it was a first or second cancer.

For example, the five-year survival rate for young adults with acute myeloid leukemia was 57 percent if it was a first cancer, but only 29 percent if it was a second cancer. The five-year survival rate for young adult women with breast cancer was 81 percent if it was a first cancer but only 63 percent if it was a second cancer.

It's not clear why younger patients tend to do worse than older patients with the same second cancers.

But the researchers suggested several possible reasons, including worse response to treatment, limitations on the types or doses of treatments that they can receive as a result of prior cancer treatment, or reduced physical reserves that lower their ability to tolerate treatment.

Mental health and social issues may also be factors.

"These younger people don't have all the support or resources they need," said study co-author Melanie Goldfarb.

"They may not have adequate insurance, or they may get lost in the system. They may suffer from depression, which can contribute to their overall health and worsen their cancer outcome," added Goldfarb, an endocrine surgeon at John Wayne Cancer Institute in Santa Monica, Calif.

The study was published April 20 in the journal JAMA Oncology.

More information

The American Cancer Society has more on second cancers.